Insider · CIK 0001597450
Karen Ling
Files at IRTC (iRhythm Holdings, Inc.), BLCO (Bausch & Lomb Corp). First filing Feb 23, 2026, latest Feb 23, 2026.
In brief
Karen Ling files SEC Form 4 as director at BLCO (Bausch & Lomb Corp), and also at IRTC (iRhythm Holdings, Inc.). Since Feb 23, 2026, Karen Ling has reported 1 open-market buy worth $71k and 0 open-market sells worth $0, the latest filed on Feb 23, 2026.
A track record needs three past buys with six months of prices behind them; Karen Ling has 0, so none is measured yet.
The newest scored trade: bought $71k of BLCO on Feb 19, 2026, filed Feb 23, 2026, scored 41 (moderate). In the last 12 months: 1 buy worth $71k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BLCO: Bausch & Lomb Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Bausch & Lomb Corp | $71k 4,000 shares | +11% | +62% from low-0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 28, 2026 | BLCO Bausch & Lomb Corp | 4,500 0.00% of outstanding | $76k | Sep 28, 2026 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | IRTC iRhythm Holdings, Inc. | AGrant or award Common Stock | +1,573 | $0.00 | $0 | 11,141 | May 29, 2026 |
| May 26, 2026 | BLCO Bausch & Lomb Corp | AGrant or award Common Shares, No Par Value | +15,842 | $15.78 | $250k | 61,518 | May 28, 2026 |
| Feb 19, 2026 | BLCO Bausch & Lomb Corp | POpen-market purchase Common Shares, No Par Value | +4,000 | $17.74 | $71k | 41,676 | Feb 23, 2026 |
| Feb 19, 2026 | BLCO Bausch & Lomb Corp | AGrant or award Common Shares, No Par Value | +4,000 | $0.00 | $0 | 45,676 | Feb 23, 2026 |
| May 28, 2025 | IRTC iRhythm Holdings, Inc. | AGrant or award Common Stock | +1,358 | $0.00 | $0 | 9,568 | May 29, 2025 |
| May 27, 2025 | BLCO Bausch & Lomb Corp | AGrant or award Common Shares, No Par Value | +20,338 | $0.00 | $0 | 37,676 | May 28, 2025 |
Questions about Karen Ling
Answered from the filings on this page, as of the latest one.
Is Karen Ling buying or selling?
In the last 12 months Karen Ling reported 1 open-market buy worth $71k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $71k of BLCO on Feb 19, 2026. Grants, option exercises and tax withholding are not counted.
How did Karen Ling's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karen Ling has 0.
Where does Karen Ling file Form 4?
Karen Ling has filed Form 4 at BLCO (Bausch & Lomb Corp); IRTC (iRhythm Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.